Grandori’s company SEngine, is preparing for a future in which cancer is not going to be treated according to cancer type – like breast or colon – but it will be treated based on its genetic underpinning.
Read more: https://www.bizjournals.com/seattle/news/2019/02/16/fred-hutch-carla-grandori-cancer-treatment.html